Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Are the Key Projections for the CAGR of the Live Attenuated Polio Vaccine Market Size From 2025 to 2034?
The market for live attenuated polio vaccine has witnessed a robust growth in the past few years. The market size, which stood at $1.85 billion in 2024, is expected to swell to $1.98 billion in 2025, growing at a compound annual growth rate (CAGR) of 7.3%. The surge in growth during the historic period is largely due to widespread immunization initiatives, rising cases of vaccine-derived poliovirus, government-sponsored immunization plans, heightened public awareness and education about the disease, and the ease of vaccine access and affordability.
Expectations are high for robust expansion in the live attenuated polio vaccine market in the ensuing years, growing to$2.65 billion in 2029 at a compound annual growth rate (CAGR) of 7.6%. The anticipated growth in this period is ascribed to factors such as enhanced vaccine stability and longevity, the reemergence of polio in volatile regions, wavering dedication from donors to eradication attempts, the enlargement of regular immunization schedules, and a hike in R&D for safer live attenuated vaccine strains. The forecast period is set to see significant trends such as the surfacing of vaccine-derived poliovirus, the production of oral polio vaccines, advancements in vaccine formulation technology, the incorporation of digital technologies, and alliances between public and private sectors.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24280&type=smp
How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theLive Attenuated Polio Vaccine Market?
The live attenuated polio vaccine (LAPV) market is projected to experience considerable growth due to the expansion of immunization initiatives. Such programs are organized by health bodies, governments, and related institutions with an aim to distribute vaccines and curb the spread of infectious diseases. Increased global cognizance of disease prevention and significant backing from international health organizations, governments, and funding entities predominantly fuel this expansion. Widespread distribution, safe administration, and extensive coverage provided by these immunization programs boost LAPV through the enhancement of herd immunity, prevention of virus propagation, and substantial contributions toward global polio eradication. As an illustration, the Centers for Disease Control and Prevention, a US-based public health agency, reported in October 2023 that the worldwide coverage of the first dose of the diphtheria-tetanus-pertussis (DTP) vaccine has escalated from 86% to 89% between 2021 and 2022. As a result, the accelerating expansion of immunization programs is propelling the LAPV market’s growth.
Which Segments in the Live Attenuated Polio Vaccine Offer the Most Growth?
The live attenuated polio vaccinemarket covered in this report is segmented –
1) By Vaccine Type: Monovalent; Bivalent; Trivalent
2) By Administration Route: Oral Administration; Intramuscular Injection; Subcutaneous Injection
3) By Age Group: Infants (0-1 years); Children (1-5 years); Adults (Above 5 years)
4) By End-User: Hospitals; Clinics; Public Health Agencies; Other End-Users
Subsegments:
1) Monovalent: mOPV1 For Serotype 1
2) Bivalent: Type 1; Type 3
3) Trivalent: Poliovirus Type 1; Poliovirus Type 2; Poliovirus Type 3
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=24280&type=smp
What Are the Fastest-Growing Geographies in the #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theLive Attenuated Polio Vaccine Market?# Market?
North America was the largest region in the live attenuated polio vaccine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the live attenuated polio vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Current Market Growth and Trends in the Live Attenuated Polio Vaccine Industry?
Companies leading the live attenuated polio vaccine market are prioritizing the acquisition of regulatory consents, ensuring their vaccines adhere to safety and efficiency standards instituted by global health organizations. Such approvals are formal permissions given by governmental health departments or regulating entities, which authorize the marketing, selling, and usage of a product, like a vaccine, within a particular area or country. For example, in July 2024, Biological E, a pharmaceutical and biologics firm based in India, obtained WHO’s approval for its new oral polio vaccine type 2 (nOPV2). This is an evolved live, oral vaccine aimed at overcoming the issues related to traditional oral polio vaccines. This evolved vaccine is intended to effectively tackle circulating vaccine-derived poliovirus type 2 (cVDPV2) outbreaks better than the previous ones. Its enhanced genetic stability decreases the probability of the vaccine virus reverting back to a harmful form, an issue usually associated with older vaccines.
View the full report here:
https://www.thebusinessresearchcompany.com/report/live-attenuated-polio-vaccine-global-market-report
What Are the Key Elements That Define the Live Attenuated Polio Vaccine Market?
The live attenuated polio vaccine (LAPV) is an oral polio vaccine (OPV) that contains a weakened form of the poliovirus that stimulates a strong immune response without causing disease in healthy individuals. It mimics natural infection, offering long-lasting immunity and helping prevent virus transmission within communities.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24280
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model